| Followers | 433 |
| Posts | 31258 |
| Boards Moderated | 1 |
| Alias Born | 11/28/2006 |
Monday, April 08, 2019 8:12:51 AM
In the case of a shelf registration statement on
Form S-3 or Form F-3, the registration statement
incorporates by reference the issuer’s reports filed
under the Securities Exchange Act of 1934 (the
“Exchange Act”) after the shelf registration statement’s
effective date. This enables the issuer to use a
registration statement that became effective before the
occurrence of material developments in its business,
without the need to file a post-effective amendmen tmixed offering.
hmm,Looks like something big happening, we should know more in a couple days
Form S-3 or Form F-3, the registration statement
incorporates by reference the issuer’s reports filed
under the Securities Exchange Act of 1934 (the
“Exchange Act”) after the shelf registration statement’s
effective date. This enables the issuer to use a
registration statement that became effective before the
occurrence of material developments in its business,
without the need to file a post-effective amendmen tmixed offering.
hmm,Looks like something big happening, we should know more in a couple days
All my posts are my opinion which should not to be taken as financial advice, and should be treated as only
for entertainment purposes!
Recent DSS News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 08:53:21 PM
- DSS, Inc. Letter to Shareholders • GlobeNewswire Inc. • 04/15/2026 08:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 09:00:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:30:59 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/17/2026 09:30:13 PM
- Form PRER14C - Information statements • Edgar (US Regulatory) • 02/06/2026 08:19:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 10:06:08 PM
- DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 02/05/2026 02:45:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/05/2026 12:46:51 PM
- DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 02/04/2026 01:35:00 PM
- DSS, Inc. Announces Launch of Proposed Public Offering • GlobeNewswire Inc. • 02/04/2026 01:17:01 AM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 01/14/2026 09:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:25:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 08:48:41 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 10/21/2025 06:04:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/20/2025 01:47:13 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/03/2025 01:50:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2025 01:43:10 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2025 08:13:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 08:53:38 PM
- DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger • GlobeNewswire Inc. • 06/24/2025 12:30:00 PM
- DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth • GlobeNewswire Inc. • 05/22/2025 12:31:00 PM
